(Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is a stable and specific full agonist for the human GIP receptor (hGIPR) with a high binding affinity, represented by K i / K d values of 0.90 nM. It shows efficacy in targeting hGIPR, making it suitable for obesity-related diabetes research [1] [2].